Make smarter investment decisions with STAT Expert Advantage — a new conference call subscription service from STAT and Slingshot Insights. Join monthly interviews led by STAT’s national biotech team with influential Key Opinion Leaders. Calls cover timely topics that are top of mind for healthcare, pharma and biotech executives, and investors — from clinical trial results and FDA drug approvals, to D.C. policy issues that will affect the entire healthcare landscape.

STAT Expert Advantage subscribers can access all 12 calls through the year for a flat rate of $500. Each call is fully compliant, and subscribers can submit their most pressing questions to these leading industry expert. If you can’t make it live, you can always access every call recording and full transcript from past calls.

Curious whether it works? Check out our Amarin case study to see how Slingshot & STAT Plus has helped investors make smarter choices.